Oral iloprost improves endobronchial dysplasia in former smokers. - Wikidata - awgldk - TriplyDB

Oral iloprost improves endobronchial dysplasia in former smokers.

Oral iloprost improves endobronchial dysplasia in former smokers.

http://www.wikidata.org/entity/Q35652044

about

Lung cancer chemoprevention: current status and future prospects Chemoprevention of lung cancer: prospects and disappointments in human clinical trials Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.Altered histology provides a positive clinical signal in the bronchial epithelium.The BATTLE to personalize lung cancer prevention through reverse migration.Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer.Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer How do we safely get people to stop smoking?Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma.Randomized phase II trial of sulindac for lung cancer chemoprevention.Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers.Lung cancer screening update.Personalizing lung cancer prevention through a reverse migration strategy.Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.Lung cancer chemoprevention: difficulties, promise and potential agents?Detection and minimally invasive treatment of early squamous lung cancer.The Second Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model.Platelet-targeted pharmacologic treatments as anti-cancer therapy.AJRCCM: 100-Year Anniversary. The Shifting Landscape for Lung Cancer: Past, Present, and Future.Application of SNP microarrays to the genome-wide analysis of chromosomal instability in premalignant airway lesions.Prostacyclin reverses the cigarette smoke-induced decrease in pulmonary Frizzled 9 expression through miR-31.Preinvasive Endobronchial Lesions: Lung Cancer Precursors and Risk Markers?Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop.Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention

P2860

Q26995495-B34AB8D6-6CE6-4020-A116-87E43FEC4189 Q28386632-A554E2E1-EC3C-4305-AADE-D15A8692DA59 Q28388931-700DF40E-2C4A-4ADB-B012-BC8A3CE014AA Q34156076-D908D42A-37D5-49C0-BE0F-F7F101FA7D32 Q34977797-C012624B-E75B-4E62-8A8F-D4A3C23ECD69 Q35033296-2B0B6EF2-A9B3-4593-838C-C026E0FD12D9 Q35208501-E65B04BB-A4F5-441F-9F93-472551F373EE Q35761033-15F5D1AF-3566-4163-B656-2D5A7B6E209C Q35870692-BDAADCB9-606B-4FD1-8C73-7F0B483B674B Q36021953-B9B4A61B-BB46-4E1F-8A99-0082836227FC Q36023746-033E97FB-7EE8-4098-B505-0752B224AEA7 Q36248969-CC76743C-41BD-4C53-BAFF-B7E5081568D2 Q36446587-E4C0E40A-F6F2-4CE4-94E8-CEF545DDFB44 Q36592529-2D084786-A36B-45B4-AA47-AE9CBA698774 Q36625590-8A7995BE-3BC0-459A-B66C-D629B8F32C9A Q36754898-2939182B-6863-4CAA-A90F-F34A463BC0A7 Q37080513-02E271CA-6922-4DC9-8FA8-A1C0BEDA36CE Q37111529-7F1C02A2-B078-4B72-8EFC-0DC48C619DC7 Q37470702-0C206B7D-B3ED-4BF4-B12D-802413599125 Q38061199-148D2D78-083C-4323-BD8D-566BF6289AB9 Q38121871-846F65C1-FC64-4731-9675-C699C03E5B9E Q38635953-3104D7AE-3D0E-4656-9085-6DFE494D42E2 Q38657846-78F79F81-4F1C-44E3-B4E3-FA12583BAFA0 Q38689104-D21643C0-A454-4309-B740-3952BA75BE81 Q39042489-434BA3DF-7FF7-424A-9187-B93ABCE8A81C Q42544523-BC176955-AB97-44A0-92F2-4BCBD658FCB0 Q43062782-93CDA84D-E3B6-4F69-866A-E548A9EB4E58 Q49667007-4500D4CA-A56C-45AB-A0BA-1818CF16B491 Q57135311-616A6679-EAF6-4014-B86C-699DFFFA9058

P2860

Oral iloprost improves endobronchial dysplasia in former smokers.

http://www.wikidata.org/entity/Q35652044

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Oral iloprost improves endobronchial dysplasia in former smokers.

@ast

Oral iloprost improves endobronchial dysplasia in former smokers.

@en

type

label

Oral iloprost improves endobronchial dysplasia in former smokers.

@ast

Oral iloprost improves endobronchial dysplasia in former smokers.

@en

prefLabel

Oral iloprost improves endobronchial dysplasia in former smokers.

@ast

Oral iloprost improves endobronchial dysplasia in former smokers.

@en

P1433

Q35652044-08144F7B-77B9-4D07-9D30-E7BF96133A26

P1476

Q35652044-E90CC3AF-66FC-4D49-942A-334D9C3FE40E

P2093

Q35652044-10D8CB08-AD20-4B95-B9CE-CF09B5BD6633

Q35652044-1BC33E45-9D0E-4D75-A55F-BE0ECBF6DCE3

Q35652044-31C2CE98-6533-48EA-AC2F-B7538BFC959B

Q35652044-4D93773D-0F70-4486-B08B-F3723F507759

Q35652044-5F4030C1-CBC9-4549-A8DA-023B55DE121C

Q35652044-642364E7-4208-42EA-B265-B931BAFA47CA

Q35652044-7ED3E94C-5235-4DE9-99CA-6945972FD805

Q35652044-7FB8BAE7-3C30-4F90-83F7-C8C7A7E3CAAF

Q35652044-8E1B27DB-F69C-430D-BB1E-4937BEC92F1F

Q35652044-962AE904-0B99-4821-8902-D8D8FBCFB828

P2860

Q35652044-078A8FA0-37B9-4F6C-8FD8-F193E6C1A984

Q35652044-07EAF1BC-CB7E-401F-847A-A956D97F858F

Q35652044-11EC87A2-1835-4FAF-9E95-F7713C562E1C

Q35652044-1508A758-41EF-499F-8017-BC5B9383DC88

Q35652044-1C7962B5-8AF9-4538-AEBA-F67C28922CC8

Q35652044-22A53B46-0F31-4CAC-958A-2F62D5BB25A7

Q35652044-2992461E-7CE9-4A16-A649-F892C1A1BE6F

Q35652044-2AE8DAAE-B67A-422B-A321-6EC73EF2FB55

Q35652044-45E8A1F8-3C68-4578-B784-95A1EB7EE3DF

Q35652044-4CB0934C-691C-4CB6-976C-9330FBE2F8F8

P304

Q35652044-7547C35E-B324-4051-BB17-9243A0C05458

P31

Q35652044-4F9106BD-4615-4A3F-8826-4A079D6ACB86

P356

Q35652044-299A1274-1FFA-45B6-AB2E-1D14410CB6AE

P433

Q35652044-67E7682D-130A-4082-916D-93F1D3D2DEC1

P478

Q35652044-EFEDB356-0E56-4D01-99F3-314CFF84DD7E

P50

Q35652044-74B57FCE-C5FC-49F9-82BA-F51B1B3D5574

P577

Q35652044-2EACB3CE-3CE4-4AB8-8EE6-7C4C810024C7

P698

Q35652044-E3EC8618-B65E-48FC-BAF2-DF14F6C9A3A4

P932

Q35652044-8ED4AC06-0024-4EE3-B875-2566A03DD636

P356

1940-6207.CAPR-11-0057

P1433

Cancer Prevention Research

P1476

Oral iloprost improves endobronchial dysplasia in former smokers.

@en

P2093

Daniel T Merrick

http://www.w3.org/2001/XMLSchema#string

David O Wilson

http://www.w3.org/2001/XMLSchema#string

Fred R Hirsch

http://www.w3.org/2001/XMLSchema#string

Jenny Mao

http://www.w3.org/2001/XMLSchema#string

John D Minna

http://www.w3.org/2001/XMLSchema#string

John Kittelson

http://www.w3.org/2001/XMLSchema#string

Mark W Geraci

http://www.w3.org/2001/XMLSchema#string

Patrick J Blatchford

http://www.w3.org/2001/XMLSchema#string

Paul A Bunn

http://www.w3.org/2001/XMLSchema#string

Pierre P Massion

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Celecoxib for the prevention of colorectal adenomatous polyps

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

Biological activity of celecoxib in the bronchial epithelium of current and former smokers.

Variations in lung cancer risk among smokers.

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.

P304

793-802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-11-0057

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21636546

http://www.w3.org/2001/XMLSchema#string

P932

3251330

http://www.w3.org/2001/XMLSchema#string